Skip to main content

Table 4 Associations between CD163+ macrophages infiltration and clinicopathological variables in all cases

From: Prognostic value of tumor-infiltrating CD163+macrophage in patients with metastatic gastric cancer undergoing multidisciplinary treatment

Variables

CD163 low (n = 28)

CD163 high (n = 40)

p-value

Age, years

66.0(47–78)

67.0(30–78)

0.992

Sex, n(%)

23/5

33/7

0.970

Performance status

25/3

32/8

0.306

Histological differentiation Intestinal/diffuse

17/11

22/18

0.639

Multiple non-curative factors -/+

19/9

20/20

0.143

Yoshida’s category 1/2

13/15

10/30

0.067

Hematogenous -/+

17/11

20/20

0.382

Lymphogenous -/+

6/22

15/25

0.158

Albumin < 3.8 / ≥ 3.8

7/21

30/10

0.001 < 

NLR < 3.1 / ≥ 3.1

17/11

15/25

0.008

PLR < 188.7 / ≥ 188.7

16/12

17/23

0.234

LMR ≥ 3.7 / < 3.7

9/19

23/17

0.039

  1. NLR Neutrophil to lymphocyte ratio, PLR Platelet to lymphocyte ratio, LMR Lymphocyte to monocyte ratio